| Ticker Details |
Haemonetics Corporation
Haemonetics Corp is a health care company. It provides products enabling in the processing, handling and analysis of blood and portfolio of integrated devices and information management tools to improve clinical outcomes.
|
| IPO Date: |
January 3, 1994 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$2.84B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.76 | 1.21%
|
| Avg Daily Range (30 D): |
$1.10 | 1.61%
|
| Avg Daily Range (90 D): |
$0.98 | 1.43%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.36M |
| Avg Daily Volume (30 D): |
.78M |
| Avg Daily Volume (90 D): |
.7M |
| Trade Size |
| Avg Trade Size (Sh.): |
94 |
| Avg Trade Size (Sh.) (30 D): |
48 |
| Avg Trade Size (Sh.) (90 D): |
46 |
| Institutional Trades |
| Total Institutional Trades: |
9,183 |
| Avg Institutional Trade: |
$2.77M |
| Avg Institutional Trade (30 D): |
$3.86M |
| Avg Institutional Trade (90 D): |
$4.02M |
| Avg Institutional Trade Volume: |
.04M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.94M |
| Avg Closing Trade (30 D): |
$9.19M |
| Avg Closing Trade (90 D): |
$8.78M |
| Avg Closing Volume: |
55.71K |
|
|
| Financials |
| |
TTM |
Q3 2026 |
Q2 2026 |
|
Basic EPS
|
$3.64
|
$.96
|
$.81
|
|
Diluted EPS
|
$3.63
|
$.95
|
$.81
|
|
Revenue
|
$1.32B
|
$338.97M
|
$327.32M
|
|
Gross Profit
|
$782.42M
|
$202.39M
|
$194.74M
|
|
Net Income / Loss
|
$175.44M
|
$44.74M
|
$38.68M
|
|
Operating Income / Loss
|
$251.09M
|
$67.4M
|
$58.49M
|
|
Cost of Revenue
|
$535.85M
|
$136.58M
|
$132.57M
|
|
Net Cash Flow
|
$42.52M
|
$66.94M
|
$3.53M
|
|
PE Ratio
|
16.99
|
|
|
|
|
|
